{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:54:58Z","timestamp":1785354898025,"version":"3.55.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/wnf.0b013e31821c31d8","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T13:29:01Z","timestamp":1305638941000},"page":"95-100","source":"Crossref","is-referenced-by-count":17,"title":["Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease"],"prefix":"10.1097","volume":"34","author":[{"given":"Mouna","family":"Esmaeilzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Kullingsj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Varrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Tedroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease.","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ana.410380602","article-title":"Selective neurodegeneration in Huntington's disease.","volume":"38","author":"Albin","year":"1995","journal-title":"Ann Neurol"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/nimg.1995.1017","article-title":"Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI.","volume":"2","author":"Jueptner","year":"1995","journal-title":"Neuroimage"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/brain\/120.8.1315","article-title":"Metabolic correlates of pallidal neuronal activity in Parkinson's disease.","volume":"120","author":"Eidelberg","year":"1997","journal-title":"Brain"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","article-title":"Metabolic brain networks associated with cognitive function in Parkinson's disease.","volume":"34","author":"Huang","year":"2007","journal-title":"Neuroimage"},{"key":"R9-1-20210203","first-page":"1591","article-title":"Metabolic network abnormalities in early Huntington's disease: an 18FFDG PET study.","volume":"42","author":"Feigin","year":"2001","journal-title":"J Nucl Med"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington's disease.","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2009.11.025","article-title":"The dopaminergic stabilizers pridopidine (ACR16) and ()-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties.","volume":"628","author":"Dyhring","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2010.07.023","article-title":"In vivo pharmacology of the dopaminergic stabilizer pridopidine.","volume":"644","author":"Ponten","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNF.0b013e3181ebb285","article-title":"Efficacy and safety of the dopaminergic stabilizer pridopidine (ACR16) in patients with Huntington's disease.","volume":"33","author":"Lundin","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: reliability and consistency.","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004728-199401000-00023","article-title":"The ECAT EXACT HR: performance of a new high resolution positron scanner.","volume":"18","author":"Wienhard","year":"1994","journal-title":"J Comput Assist Tomogr"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0166-2236(94)90131-7","article-title":"Brain atlases-a new research tool.","volume":"17","author":"Roland","year":"1994","journal-title":"Trends Neurosci"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ana.410140604","article-title":"In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.","volume":"14","author":"Rhodes","year":"1983","journal-title":"An Neurol"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1148\/radiology.188.1.8511286","article-title":"Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve.","volume":"188","author":"Takikawa","year":"1993","journal-title":"Radiology"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hbm.20345","article-title":"Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template.","volume":"28","author":"Lancaster","year":"2007","journal-title":"Hum Brain Mapp"},{"key":"R23-1-20210203","first-page":"559","article-title":"On lines and planes of closest fit to systems of points in space.","volume":"2","author":"Pearson","year":"1901","journal-title":"Philosophical Magazine"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00401706.1978.10489693","article-title":"Cross-validatory estimation of the number of components in factor and principal component models.","volume":"20","author":"Wold","year":"1978","journal-title":"Technometrics"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1214\/aoms\/1177732979","article-title":"The generalization of Student's ratio.","volume":"2","author":"Hotelling","year":"1931","journal-title":"Ann Math Stat"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.neuropsychologia.2006.12.023","article-title":"Increased cortical recruitment in Huntington's disease using a Simon task.","volume":"45","author":"Georgiou-Karistianis","year":"2007","journal-title":"Neuropsychologia"},{"key":"R30-1-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pscychresns.2004.03.002","article-title":"Functional MRI study of a serial reaction time task in Huntington's disease.","volume":"131","author":"Kim","year":"2004","journal-title":"Psychiatry Res"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.20684","article-title":"Preclinical Huntington's disease: compensatory brain responses during learning.","volume":"59","author":"Feigin","year":"2006","journal-title":"Ann Neurol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-201105000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:52:22Z","timestamp":1618278742000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201105000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31821c31d8","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}